Vagus nerve stimulation modulating the directed brain network of patients with drug-resistant epilepsy
Mingming Chen,
No information about this author
Kunlin Guo,
No information about this author
Yongqiang Ding
No information about this author
et al.
Biomedical Signal Processing and Control,
Journal Year:
2024,
Volume and Issue:
95, P. 106361 - 106361
Published: April 19, 2024
Language: Английский
Successful application of vagus nerve stimulation in super refractory status epilepticus associated with MERRF syndrome
Leyla Baysal-Kıraç,
No information about this author
Sabrina Jobi,
No information about this author
S. Zimmermann
No information about this author
et al.
Epilepsy & Behavior Reports,
Journal Year:
2025,
Volume and Issue:
unknown, P. 100769 - 100769
Published: April 1, 2025
Language: Английский
Application of Neuromodulation Techniques in Super-Refractory Status Epilepticus
灵 王
No information about this author
Advances in Clinical Medicine,
Journal Year:
2025,
Volume and Issue:
15(04), P. 1720 - 1727
Published: Jan. 1, 2025
Language: Английский
The effect of vagus nerve stimulation on heart rate and respiration rate and their impact on seizure susceptibility in anaesthetized rats under pentylenetetrazol
Frontiers in Neuroscience,
Journal Year:
2025,
Volume and Issue:
19
Published: March 21, 2025
Despite
the
proven
efficacy
of
vagus
nerve
stimulation
(VNS)
in
seizure
control,
its
precise
mechanism
action
remains
unclear.
VNS
is
known
to
impact
cardiorespiratory
system.
In
this
study,
we
explored
effects
standard
and
breathing-synchronized
on
heart
respiratory
rates
anesthetized
epileptic
rats,
as
well
their
susceptibility.
Seizures
were
induced
rats
by
intravenous
pentylenetetrazol
(PTZ)
infusion.
Three
animal
groups
(
n
=
4)
subjected
different
types
stimulation:
Sham
VNS,
Standard
Breathing-Synchronized
VNS.
Measurements
included
respiration,
electrocardiogram,
electroencephalogram,
vagal
electroneurogram.
Each
experiment
began
with
a
5-min
baseline
period,
followed
PTZ
infusion
until
tonic–clonic
onset,
confirmed
video
recording
electroencephalogram.
Results
indicate
that
significantly
decreased
rate
below
levels
for
(−120.0
±
69.1
bpm)
(−84.9
61.0
bpm),
overcoming
increasing
effect
observed
sham
(+79.2
35.5
there
was
no
recovery
during
OFF
periods.
Regarding
breathing
changes,
group
presented
slight
increase
respect
(+13.6
1.8
bpm).
The
slightly
increased
average
(+13.0
14.6
(+13.7
10.4
however
enlarged
deviation.
More
specifically,
pattern
suggests
experienced
hypoxia
under
stimulation.
modulation
similar
suggesting
cumulative.
Unexpectedly,
required
higher
dose
(79.7
13.4
mg/kg)
reach
seizures
compared
(57.9
9.8
mg/kg),
(60.0
8.7
pointing
an
susceptibility
particular
model.
Additionally,
latency
longer
(291.5
84.4
s)
(200.5
59.5
(206.9
66.0
s),
meaning
starting
earlier.
A
significant
linear
relationship
found
between
R
2
0.62,
p
-value
0.012).
We
hypothesize
drop
presence
altered
respiration
patterns,
such
apneas
or
changes
rates,
caused
are
related
hypotension
conditions,
which
could
PTZ.
Future
investigations
larger
sample
sizes,
incorporating
blood
pressure
oxygen
saturation
monitoring,
needed
sort
out
role
potential
covariates
affecting
overstimulation.
Such
finding
would
support
idea
safety
require
adjustments.
Language: Английский
A Comprehensive Overview of the Current Status and Advancements in Various Treatment Strategies against Epilepsy
ACS Pharmacology & Translational Science,
Journal Year:
2024,
Volume and Issue:
7(12), P. 3729 - 3757
Published: Nov. 1, 2024
Epilepsy
affects
more
than
70
million
individuals
of
all
ages
worldwide
and
remains
one
the
most
severe
chronic
noncommunicable
neurological
diseases
globally.
Several
neurotransmitters,
membrane
protein
channels,
receptors,
enzymes,
and,
recently
noted,
various
pathways,
such
as
inflammatory
mTORC
complexes,
play
significant
roles
in
initiation
propagation
seizures.
Over
past
two
decades,
developments
have
been
made
diagnosis
treatment
epilepsy.
Various
pharmacological
drugs
with
diverse
mechanisms
action
other
options
developed
to
control
seizures
treat
These
include
surgical
treatment,
nanomedicine,
gene
therapy,
natural
products,
nervous
stimulation,
a
ketogenic
diet,
gut
microbiota,
etc.,
which
are
developmental
stages.
Despite
plethora
options,
one-third
affected
resistant
current
medications,
while
majority
approved
side
effects,
changes
can
occur,
pharmacoresistance,
effects
on
cognition,
long-term
problems,
drug
interactions,
risks
poor
adherence,
specific
for
certain
psychological
complications.
Therefore,
development
new
that
no
or
minimal
adverse
is
needed
combat
this
deadly
disease.
In
Review,
we
comprehensively
summarize
explain
stages
epilepsy
well
their
status
clinical
trials
advancements.
Language: Английский
Role of Vagus Nerve Stimulation in Refractory and Super Refractory Status Epilepticus: A Pediatric Case Series
Brain Sciences,
Journal Year:
2023,
Volume and Issue:
13(11), P. 1589 - 1589
Published: Nov. 14, 2023
Background:
Status
epilepticus
is
a
life-threatening
condition
that
defined
as
refractory
(RSE)
when
the
seizure
activity
continues
despite
treatment
with
benzodiazepine
and
second
appropriate
treatment.
Super
status
(SRSE)
an
RSE
persists
or
recurs
for
≥24
h.
Few
papers
have
reported
outcomes
of
pediatric
patients
affected
by
SRSE
treated
neuromodulation
therapies.
Vagus
nerve
stimulation
(VNS)
approved
drug-resistant
epilepsy.
We
present
our
findings
VNS
RSE/SRSE.
Methods:
case
series
seven
consecutive
since
2012
single
surgeon
in
Monza
Padua.
A
rapid
titration
was
started
soon
after
implantation.
considered
electroclinical
data
before
implantation
at
last
follow-up.
Results:
achieved
resolution
five
out
mean
time
two
weeks.
At
follow-up,
these
had
significant
reduction
burden
without
any
relapse
SE.
Discussion
Conclusions:
Based
on
limited
findings,
we
discuss
potential
role
therapy
similar
but
distinct
clinical
contexts.
For
epilepsy
RSE/SRSE,
prompt
consideration
suggested,
offering
responses
potentially
reducing
pharmacological
load.
Meanwhile,
NORSE/FIRES,
suggest
early
during
acute
phase
if
standard
treatments
prove
ineffective
not
tolerated.
This
approach
may
leverage
VNS’s
anti-inflammatory
effects
neuromodulation,
enhancing
patient-specific
treatments.
Expanding
studies
prolonged
follow-ups
are
recommended
to
strengthen
insights.
Language: Английский
NEUROMODULATION IN EPILEPSY: AN UPDATED REVIEW AND FUTURE PERSPECTIVES
Lucas de Freitas Sommer,
No information about this author
Laurence Vezzani Ruschel,
No information about this author
Vanessa Lopes Senssulini
No information about this author
et al.
International Journal of Health Science,
Journal Year:
2024,
Volume and Issue:
4(11), P. 2 - 8
Published: Jan. 24, 2024
Objective:
Evaluate
and
synthesize
the
most
recent
scientific
evidence
on
neuromodulation
techniques
used
in
treatment
of
epilepsy,
focusing
advances
future
perspectives.Methodology:
Narrative
bibliographic
review
using
PubMed
database,
search
terms
"Neuromodulation",
"Transcutaneous
Electric
Nerve
Stimulation",
"Deep
Brain
"Vagal
"Epilepsy",
associated
with
Boolean
operators
"OR"
"AND",
resulting
982
articles,
which
only
18
became
official
sources
study
after
applying
inclusion
exclusion
criteria.Discussion:
Studies
demonstrate
that
are
effective
safe
reducing
number
seizures
patients
epilepsy.Furthermore,
it
has
direct
effects
quality
life
a
greater
probability
survival
patients,
especially
those
epilepsy
refractory
to
drug
Final
Considerations:
The
lack
specific
guidelines,
such
as
intensity
frequency
stimulation,
results
heterogeneous
longterm
effects.Therefore,
studies
needed
understand
factors
influence
these
develop
even
more
stimulation
protocols.
Language: Английский
Integrating the 5-SENSE Score for Patient Selection in Vagus Nerve Stimulation for Drug-Resistant Epilepsy
Flavius Iuliu Urian,
No information about this author
Radu Eugen Rizea,
No information about this author
Horia Petre Costin
No information about this author
et al.
Cureus,
Journal Year:
2024,
Volume and Issue:
unknown
Published: Aug. 28, 2024
Addressing
the
challenge
of
drug-resistant
epilepsy,
our
study
offers
a
novel
perspective
by
retrospectively
applying
5-SENSE
score,
initially
created
for
stereoelectroencephalography
(SEEG)
planning,
to
evaluate
its
predictive
value
in
patients
undergoing
vagus
nerve
stimulation
(VNS)
therapy.
We
conducted
comprehensive
preoperative
diagnostic
work-up,
including
computed
tomography
(CT),
magnetic
resonance
imaging
(MRI),
positron
emission
tomography-CT
(PET-CT),
video-electroencephalogram
(video-EEG),
and
clinical
semiology.
then
stratified
76
into
three
groups
-
low,
moderate,
high
focality
based
on
seizure-onset
zone.
Such
stratification
was
made
check
scoring
ability
predicting
VNS
therapy
seizure
reduction.
Our
findings
demonstrate
an
association
between
extent
at
zone
effectiveness
VNS,
which
may
help
define
role
score
patient
selection
VNS.
This
dispersion
responses
group
with
reinforces
idea
that
outcome
estimation
is
difficult
argues
individualized
strategy
treatment
epilepsy.
A
level
indicates
importance
detailed
assessments
better
optimize
further
improve
outcomes.
Language: Английский
Status Epilepticus Treated With Vagus Nerve Stimulation in an Adult With Cortical Dysplasia: A Case Report
Irene Gómez-Oropeza,
No information about this author
Valeria I Bravo-Osorno,
No information about this author
María F Castelo-Pablos
No information about this author
et al.
Cureus,
Journal Year:
2024,
Volume and Issue:
unknown
Published: Dec. 18, 2024
Status
epilepticus
(SE)
is
a
neurological
emergency
characterized
by
prolonged
seizures,
with
significant
risks
of
neuronal
injury
and
mortality.
This
case
presents
60-year-old
man
drug-resistant
epilepsy
history
recurrent
seizures.
His
seizures
began
in
early
childhood
persisted
despite
multiple
anti-seizure
medications.
Notably,
his
semiology
included
the
chapeau
de
gendarme
sign,
suggesting
an
involvement
anterior
cingulate
cortex
frontal
lobe.
Brain
MRI
revealed
cortical
dysplasia
right
inferior
gyrus.
Given
high
risk
sudden
unexpected
death
(SUDEP)
due
to
frequent
generalized
tonic-clonic
vagus
nerve
stimulation
(VNS)
was
considered
alternative
therapy,
future
evaluation
for
surgical
intervention
involving
lesionectomy.
Following
VNS
implantation,
SE
arrested
standard
titration,
within
six
months,
patient
achieved
seizure
freedom.
demonstrates
use
controlling
SE.
Further
research
necessary
determine
optimal
protocols
Language: Английский